Skip to content

The Safety and Efficacy Evaluation of Hair Products Containing Probiotics

Testing of Hair Products Containing Probiotics

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04566549
Enrollment
21
Registered
2020-09-28
Start date
2020-07-06
Completion date
2021-02-06
Last updated
2021-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Problems

Keywords

Hair health, Scalp health, Probiotics, Scalp microbiota

Brief summary

Previous studies on skin health with Lactic acid bacteria (LAB) have been published for many years, including prevention of skin diseases and improvement of skin conditions. In this clinical study, the investigators researched the benefit effects of heat-killed Lactobacillus paracasei shampoo on scalp and hair healthcare.

Detailed description

To evaluate the safety and efficacy of hair products containing probiotics

Interventions

COMBINATION_PRODUCTTest group Probiotic Shampoo

Probiotic Shampoo

COMBINATION_PRODUCTPlacebo group

Shampoo base

Sponsors

Chia Nan University of Pharmacy and Science
CollaboratorOTHER
GenMont Biotech Incorporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

\- Healthy volunteers between the ages of 20-70.

Exclusion criteria

* Subjects are undergoing medical therapy for scalp, hair diseases or diabetes mellitus. * Subjects with cosmetics allergy. * Subjects had accepted the scalp surgery such as Follicular Unit Transpalnt, Follicular Unit Extraction in the past half year. * Subjects with pregnancy or breast-feeding.

Design outcomes

Primary

MeasureTime frameDescription
Skin MicrobiotaBaseline, 4 weeks and 8 weeksThe changes of scalp microbiota will be evaluated by NGS or qPCR analysis at baseline and different timepoint post-intervention.

Secondary

MeasureTime frameDescription
The scalp flakes (dandruff)Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeksThe scalp flakes will be evaluated by D-SQAME ® DANDRUFF TESTER at baseline and different timepoint post-intervention.
The hair density (hairs/scalp area)Baseline, 4 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeksThe hair number in a constant scalp area will be measured by Aramo TSII skin/hair diagnosis (Aramhuvis Co., Ltd. Korea) at baseline and different timepoint post-intervention.
The sebum on scalpBaseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 12 weeks, 20 weeks and 28 weeksThe scalp sebum will be measured by Sebumeter SM815 (C+K, Germany) at baseline and different timepoint post-intervention.
Single application closed patch epicutaneous test under occlusion1 hour, 24 hours and 48 hourProbiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.
Repeated application closed patch epicutaneous test under occlusionDay 1, 2, 3, 4 and 5The irritation potential of probiotics on skin will be evaluated by Human Patch test. The Human Patch test method according to the Guidelines of Human Patch test Standards for Cosmetics, Taiwan Food and Drug Administration, 2019 edition.
Adverse EventBaseline and 28 weeksAny adverse event, such as erythema,rash, itching and so on will be recorded during the intervention.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026